Display Settings:

Format

Send to:

Choose Destination
    Eur J Immunol. 2009 Mar;39(3):670-5.

    Novel therapeutic targets along the Th17 pathway.

    Source

    Department of Immunology, Genentech, South San Francisco, CA 94080, USA. ouyang@gene.com

    Abstract

    The recent discovery of IL-17-producing CD4(+) Th subset significantly revised the Th1/Th2 dichotomy model proposed by Mosmann and Coffman almost two decades ago. Th17 cells are involved in the pathogenesis of many human autoimmune diseases. Th17 cells, their developmental pathways and their effector functions, therefore, provide novel therapeutic targets.

    PMID:
    19283720
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for John Wiley & Sons, Inc.

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk